 | • レポートコード：MRC2-11QY12203 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHIVワクチンのグローバル市場について調査・分析したレポートです。種類別（フェーズI、フェーズII、フェーズIII）市場規模、用途別（研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HIVワクチンの競争状況、市場シェア ・世界のHIVワクチン市場：種類別市場規模 2015年-2020年（フェーズI、フェーズII、フェーズIII） ・世界のHIVワクチン市場：種類別市場規模予測 2021年-2026年（フェーズI、フェーズII、フェーズIII） ・世界のHIVワクチン市場：用途別市場規模 2015年-2020年（研究機関、その他） ・世界のHIVワクチン市場：用途別市場規模予測 2021年-2026年（研究機関、その他） ・北米のHIVワクチン市場分析：米国、カナダ ・ヨーロッパのHIVワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHIVワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHIVワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHIVワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Argos Therapeutics、Bionor Pharma、Janssen Global Services、Genecure、Geovax,、Paxvax Corporation、Inovio Pharmaceuticals、Glaxosmithkline、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
HIV Vaccine Market has been segmented on the basis of type which comprises of acute paronychia, chronic paronychia, candidal paronychia and pyogenic paronychia. On the basis of antibiotics, market is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and others.
Globally North America is the largest market for HIV vaccine market. The large size of the market can be attributed to higher adoption of various HIV vaccine trials coupled with presence of technologically and advancement.
Market Analysis and Insights: Global HIV Vaccines Market
The global HIV Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global HIV Vaccines Scope and Market Size
HIV Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Argos Therapeutics
Bionor Pharma
Janssen Global Services
Genecure
Geovax,
Paxvax Corporation
Inovio Pharmaceuticals
Glaxosmithkline
Sanofi
Market segment by Type, the product can be split into
Phase I
Phase II
Phase III
Market segment by Application, split into
Research Institute
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Vaccines Revenue
1.4 Market by Type
1.4.1 Global HIV Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Phase I
1.4.3 Phase II
1.4.4 Phase III
1.5 Market by Application
1.5.1 Global HIV Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Research Institute
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global HIV Vaccines Market Perspective (2015-2026)
2.2 Global HIV Vaccines Growth Trends by Regions
2.2.1 HIV Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 HIV Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top HIV Vaccines Players by Market Size
3.1.1 Global Top HIV Vaccines Players by Revenue (2015-2020)
3.1.2 Global HIV Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Vaccines Market Concentration Ratio
3.2.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2019
3.3 HIV Vaccines Key Players Head office and Area Served
3.4 Key Players HIV Vaccines Product Solution and Service
3.5 Date of Enter into HIV Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HIV Vaccines Historic Market Size by Type (2015-2020)
4.2 Global HIV Vaccines Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global HIV Vaccines Market Size by Application (2015-2020)
5.2 Global HIV Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America HIV Vaccines Market Size (2015-2020)
6.2 HIV Vaccines Key Players in North America (2019-2020)
6.3 North America HIV Vaccines Market Size by Type (2015-2020)
6.4 North America HIV Vaccines Market Size by Application (2015-2020)
7 Europe
7.1 Europe HIV Vaccines Market Size (2015-2020)
7.2 HIV Vaccines Key Players in Europe (2019-2020)
7.3 Europe HIV Vaccines Market Size by Type (2015-2020)
7.4 Europe HIV Vaccines Market Size by Application (2015-2020)
8 China
8.1 China HIV Vaccines Market Size (2015-2020)
8.2 HIV Vaccines Key Players in China (2019-2020)
8.3 China HIV Vaccines Market Size by Type (2015-2020)
8.4 China HIV Vaccines Market Size by Application (2015-2020)
9 Japan
9.1 Japan HIV Vaccines Market Size (2015-2020)
9.2 HIV Vaccines Key Players in Japan (2019-2020)
9.3 Japan HIV Vaccines Market Size by Type (2015-2020)
9.4 Japan HIV Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia HIV Vaccines Market Size (2015-2020)
10.2 HIV Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Vaccines Market Size by Application (2015-2020)
11 India
11.1 India HIV Vaccines Market Size (2015-2020)
11.2 HIV Vaccines Key Players in India (2019-2020)
11.3 India HIV Vaccines Market Size by Type (2015-2020)
11.4 India HIV Vaccines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America HIV Vaccines Market Size (2015-2020)
12.2 HIV Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Vaccines Market Size by Type (2015-2020)
12.4 Central & South America HIV Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Argos Therapeutics
13.1.1 Argos Therapeutics Company Details
13.1.2 Argos Therapeutics Business Overview
13.1.3 Argos Therapeutics HIV Vaccines Introduction
13.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2015-2020))
13.1.5 Argos Therapeutics Recent Development
13.2 Bionor Pharma
13.2.1 Bionor Pharma Company Details
13.2.2 Bionor Pharma Business Overview
13.2.3 Bionor Pharma HIV Vaccines Introduction
13.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2015-2020)
13.2.5 Bionor Pharma Recent Development
13.3 Janssen Global Services
13.3.1 Janssen Global Services Company Details
13.3.2 Janssen Global Services Business Overview
13.3.3 Janssen Global Services HIV Vaccines Introduction
13.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2015-2020)
13.3.5 Janssen Global Services Recent Development
13.4 Genecure
13.4.1 Genecure Company Details
13.4.2 Genecure Business Overview
13.4.3 Genecure HIV Vaccines Introduction
13.4.4 Genecure Revenue in HIV Vaccines Business (2015-2020)
13.4.5 Genecure Recent Development
13.5 Geovax,
13.5.1 Geovax, Company Details
13.5.2 Geovax, Business Overview
13.5.3 Geovax, HIV Vaccines Introduction
13.5.4 Geovax, Revenue in HIV Vaccines Business (2015-2020)
13.5.5 Geovax, Recent Development
13.6 Paxvax Corporation
13.6.1 Paxvax Corporation Company Details
13.6.2 Paxvax Corporation Business Overview
13.6.3 Paxvax Corporation HIV Vaccines Introduction
13.6.4 Paxvax Corporation Revenue in HIV Vaccines Business (2015-2020)
13.6.5 Paxvax Corporation Recent Development
13.7 Inovio Pharmaceuticals
13.7.1 Inovio Pharmaceuticals Company Details
13.7.2 Inovio Pharmaceuticals Business Overview
13.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction
13.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2015-2020)
13.7.5 Inovio Pharmaceuticals Recent Development
13.8 Glaxosmithkline
13.8.1 Glaxosmithkline Company Details
13.8.2 Glaxosmithkline Business Overview
13.8.3 Glaxosmithkline HIV Vaccines Introduction
13.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2015-2020)
13.8.5 Glaxosmithkline Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview
13.9.3 Sanofi HIV Vaccines Introduction
13.9.4 Sanofi Revenue in HIV Vaccines Business (2015-2020)
13.9.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. HIV Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by HIV Vaccines Revenue
Table 3. Ranking of Global Top HIV Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HIV Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Phase I
Table 6. Key Players of Phase II
Table 7. Key Players of Phase III
Table 8. Global HIV Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global HIV Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global HIV Vaccines Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global HIV Vaccines Market Share by Regions (2015-2020)
Table 12. Global HIV Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global HIV Vaccines Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. HIV Vaccines Market Growth Strategy
Table 18. Main Points Interviewed from Key HIV Vaccines Players
Table 19. Global HIV Vaccines Revenue by Players (2015-2020) (Million US$)
Table 20. Global HIV Vaccines Market Share by Players (2015-2020)
Table 21. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2019)
Table 22. Global HIV Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players HIV Vaccines Product Solution and Service
Table 25. Date of Enter into HIV Vaccines Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 28. Global HIV Vaccines Market Size Share by Type (2015-2020)
Table 29. Global HIV Vaccines Revenue Market Share by Type (2021-2026)
Table 30. Global HIV Vaccines Market Size Share by Application (2015-2020)
Table 31. Global HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 32. Global HIV Vaccines Market Size Share by Application (2021-2026)
Table 33. North America Key Players HIV Vaccines Revenue (2019-2020) (Million US$)
Table 34. North America Key Players HIV Vaccines Market Share (2019-2020)
Table 35. North America HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 36. North America HIV Vaccines Market Share by Type (2015-2020)
Table 37. North America HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 38. North America HIV Vaccines Market Share by Application (2015-2020)
Table 39. Europe Key Players HIV Vaccines Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players HIV Vaccines Market Share (2019-2020)
Table 41. Europe HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 42. Europe HIV Vaccines Market Share by Type (2015-2020)
Table 43. Europe HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 44. Europe HIV Vaccines Market Share by Application (2015-2020)
Table 45. China Key Players HIV Vaccines Revenue (2019-2020) (Million US$)
Table 46. China Key Players HIV Vaccines Market Share (2019-2020)
Table 47. China HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 48. China HIV Vaccines Market Share by Type (2015-2020)
Table 49. China HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 50. China HIV Vaccines Market Share by Application (2015-2020)
Table 51. Japan Key Players HIV Vaccines Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players HIV Vaccines Market Share (2019-2020)
Table 53. Japan HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 54. Japan HIV Vaccines Market Share by Type (2015-2020)
Table 55. Japan HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 56. Japan HIV Vaccines Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players HIV Vaccines Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players HIV Vaccines Market Share (2019-2020)
Table 59. Southeast Asia HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia HIV Vaccines Market Share by Type (2015-2020)
Table 61. Southeast Asia HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia HIV Vaccines Market Share by Application (2015-2020)
Table 63. India Key Players HIV Vaccines Revenue (2019-2020) (Million US$)
Table 64. India Key Players HIV Vaccines Market Share (2019-2020)
Table 65. India HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 66. India HIV Vaccines Market Share by Type (2015-2020)
Table 67. India HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 68. India HIV Vaccines Market Share by Application (2015-2020)
Table 69. Central & South America Key Players HIV Vaccines Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players HIV Vaccines Market Share (2019-2020)
Table 71. Central & South America HIV Vaccines Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America HIV Vaccines Market Share by Type (2015-2020)
Table 73. Central & South America HIV Vaccines Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America HIV Vaccines Market Share by Application (2015-2020)
Table 75. Argos Therapeutics Company Details
Table 76. Argos Therapeutics Business Overview
Table 77. Argos Therapeutics Product
Table 78. Argos Therapeutics Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 79. Argos Therapeutics Recent Development
Table 80. Bionor Pharma Company Details
Table 81. Bionor Pharma Business Overview
Table 82. Bionor Pharma Product
Table 83. Bionor Pharma Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 84. Bionor Pharma Recent Development
Table 85. Janssen Global Services Company Details
Table 86. Janssen Global Services Business Overview
Table 87. Janssen Global Services Product
Table 88. Janssen Global Services Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 89. Janssen Global Services Recent Development
Table 90. Genecure Company Details
Table 91. Genecure Business Overview
Table 92. Genecure Product
Table 93. Genecure Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 94. Genecure Recent Development
Table 95. Geovax, Company Details
Table 96. Geovax, Business Overview
Table 97. Geovax, Product
Table 98. Geovax, Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 99. Geovax, Recent Development
Table 100. Paxvax Corporation Company Details
Table 101. Paxvax Corporation Business Overview
Table 102. Paxvax Corporation Product
Table 103. Paxvax Corporation Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 104. Paxvax Corporation Recent Development
Table 105. Inovio Pharmaceuticals Company Details
Table 106. Inovio Pharmaceuticals Business Overview
Table 107. Inovio Pharmaceuticals Product
Table 108. Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 109. Inovio Pharmaceuticals Recent Development
Table 110. Glaxosmithkline Business Overview
Table 111. Glaxosmithkline Product
Table 112. Glaxosmithkline Company Details
Table 113. Glaxosmithkline Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 114. Glaxosmithkline Recent Development
Table 115. Sanofi Company Details
Table 116. Sanofi Business Overview
Table 117. Sanofi Product
Table 118. Sanofi Revenue in HIV Vaccines Business (2015-2020) (Million US$)
Table 119. Sanofi Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Vaccines Market Share by Type: 2020 VS 2026
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Global HIV Vaccines Market Share by Application: 2020 VS 2026
Figure 6. Research Institute Case Studies
Figure 7. Other Case Studies
Figure 8. HIV Vaccines Report Years Considered
Figure 9. Global HIV Vaccines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global HIV Vaccines Market Share by Regions: 2020 VS 2026
Figure 11. Global HIV Vaccines Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global HIV Vaccines Market Share by Players in 2019
Figure 14. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2019
Figure 15. The Top 10 and 5 Players Market Share by HIV Vaccines Revenue in 2019
Figure 16. North America HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- がんワクチン薬剤用パイプラインの世界市場（～2026年） Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. Market Analysis and Insights: Global Cancer Vaccines Drug Pipeline Mark…